Therapeutic Devices · Watertown, MA · Founded 2021 · Privately Held (backing)
Developer of a targeted gene therapy intended to treat autoimmune diseases and cardiac diseases. Soufflé Therapeutics is based in Watertown, MA and was founded in 2021. It was valued at $345 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $241 million across 1 recorded round; the latest was a $200 million Series A in Oct 2025.
PMV mark · valuation
$344.5M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$240.6M
Last round
Early Stage VC (Series A)
Oct 2025
Team — not yet on record
No current team members for Soufflé Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Soufflé Therapeutics with a free account
·The complete investor list: 13 names
·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
